| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 40.6436 | 8 |
| GSM780708 | Untreated after 4 days (C2_1) | 43.7489 | 21 |
| GSM780709 | Untreated after 4 days (C3_1) | 40.7598 | 9 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.3456 | 34 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.3182 | 19 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.3757 | 19 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.2943 | 33 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.1962 | 28 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 39.1966 | 5 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.1084 | 23 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 51.7602 | 53 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 40.7074 | 8 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.6261 | 35 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.0386 | 18 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 43.2975 | 19 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.7615 | 16 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.9019 | 27 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 39.3535 | 5 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 40.4942 | 8 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.2733 | 33 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.5886 | 20 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.5937 | 30 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 46.745 | 36 |